These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12683876)

  • 1. Malignant mesothelioma does not demonstrate overexpression or gene amplification despite cytoplasmic immunohistochemical staining for c-Erb-B2.
    Horvai AE; Li L; Xu Z; Kramer MJ; Jablons DM; Treseler PA
    Arch Pathol Lab Med; 2003 Apr; 127(4):465-9. PubMed ID: 12683876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization.
    Murthy SK; Magliocco AM; Demetrick DJ
    Arch Pathol Lab Med; 2005 Jan; 129(1):39-46. PubMed ID: 15628907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
    Vlasoff DM; Baschinsky DY; De Young BR; Morrison CD; Nuovo GJ; Frankel WL
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):237-41. PubMed ID: 12373150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+ in immunohistochemical analysis.
    Lan C; Liu JM; Liu TW; Hsu DH; Liang S; Chen JR; Peng JW
    Am J Clin Pathol; 2005 Jul; 124(1):97-102. PubMed ID: 15923160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization.
    Aly MS; Khaled HM
    Urol Oncol; 2004; 22(6):448-52. PubMed ID: 15610859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions.
    Geddert H; Zeriouh M; Wolter M; Heise JW; Gabbert HE; Sarbia M
    Am J Clin Pathol; 2002 Jul; 118(1):60-6. PubMed ID: 12109857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic expression of c-erb-B2 in endometrial carcinomas.
    Lambropoulou M; Stefanou D; Alexiadis G; Tamiolakis D; Tripsianis G; Chatzaki E; Vandoros GP; Kiziridou A; Papadopoulou E; Papadopoulos N
    Onkologie; 2007 Oct; 30(10):495-500. PubMed ID: 17890888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE; Wallis T; Tabasczka P; Visscher DW
    Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.
    Doventas A; Bilici A; Demirell F; Ersoy G; Turna H; Doventas Y
    Hepatogastroenterology; 2012 Oct; 59(119):2196-201. PubMed ID: 23435135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck.
    Olsen RJ; Lydiatt WM; Koepsell SA; Lydiatt D; Johansson SL; Naumann S; Bridge JA; Neff JR; Hinrichs SH; Tarantolo SR
    Head Neck; 2005 Oct; 27(10):883-92. PubMed ID: 16158422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Her-2/neu status in breast cancer metastases to the central nervous system.
    Lear-Kaul KC; Yoon HR; Kleinschmidt-DeMasters BK; McGavran L; Singh M
    Arch Pathol Lab Med; 2003 Nov; 127(11):1451-7. PubMed ID: 14567724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of amplification of c-erb-B2 in bladder carcinoma.
    Lönn U; Lönn S; Friberg S; Nilsson B; Silfverswärd C; Stenkvist B
    Clin Cancer Res; 1995 Oct; 1(10):1189-94. PubMed ID: 9815911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
    Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
    Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-erb-B2 gene in bladder cancer of Egyptian patients and its correlation with p53 and bcl-2.
    Sakr SA; Mahran HA; Fahmy AM; El-Kholy MA; Meawad M
    Biomed Pharmacother; 2015 Dec; 76():73-81. PubMed ID: 26653553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study.
    Hirashima N; Takahashi W; Yoshii S; Yamane T; Ooi A
    Mod Pathol; 2001 Jun; 14(6):556-62. PubMed ID: 11406656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
    Nakajima M; Sawada H; Yamada Y; Watanabe A; Tatsumi M; Yamashita J; Matsuda M; Sakaguchi T; Hirao T; Nakano H
    Cancer; 1999 May; 85(9):1894-902. PubMed ID: 10223227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic endocrine tumors-c-erb B2 (Her-2/neu), bcl-2, and p-53 immunohistochemical testing and their value in assessing prognosis.
    Proca DM; Frankel WL
    Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):44-7. PubMed ID: 18091321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERBB2 amplifications in esophageal adenocarcinoma.
    Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
    Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Kit is not expressed in malignant mesothelioma.
    Horvai AE; Li L; Xu Z; Kramer MJ; Jablons DM; Treseler PA
    Mod Pathol; 2003 Aug; 16(8):818-22. PubMed ID: 12920227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?
    Sauer T; Wiedswang G; Boudjema G; Christensen H; Karesen R
    APMIS; 2003 Mar; 111(3):444-50. PubMed ID: 12752225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.